Quantcast

Latest Organic chemistry Stories

2014-10-24 12:27:03

NEW YORK, Oct. 24, 2014 /PRNewswire/ -- As Risperdal lawsuits (www.risperdallawsuit2014.com) involving gynecomastia, or male breast growth, continue to move forward in U.S. courts, Bernstein Liebhard LLP notes the publication of new research linking the use of risperidone to the development of the condition. The findings, which appear in the October 2014 issue of the Journal of Clinical Psychopharmacology, were drawn from a comparison of 8,000 men who suffered from gynecomastia, ages...

2014-10-23 16:27:14

LONDON, Oct. 23, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Artificial Sweeteners in US$ Thousands by the following Major Product Classes: Aspartame, Acesulfame Potassium, Saccharin, Sucralose, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is...

2014-10-23 16:25:56

Entrenchment of Current Analgesics and Increasing Cost Sensitivity Will Hamper Uptake of Emerging Acute Pain Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 23, 2014 /PRNewswire/ -- Decision Resources Group finds that the acute pain market will grow minimally from $12.7 billion in 2013 to $13.3 billion in 2023 across the major pharmaceutical markets (United States, France, Germany, Italy, Spain, the United Kingdom and Japan), representing an annual...

2014-10-23 12:30:28

Lamotrigine Still Retains the Leading Patient Share Among Recently Treated Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 23, 2014 /PRNewswire/ -- Decision Resources Group finds that, through analysis of U.S. longitudinal patient-level claims data, Abilify (Bristol-Myers Squibb/Otsuka) was the antipsychotic that captured the highest first-line patient share among newly diagnosed bipolar disorder patients. Although multiple generic antipsychotics are...

2014-10-22 23:04:17

RnRMarketResearch.com adds “Market Research Report on Global and Chinese Erythromycin Industry, 2009-2019” Latest Report to its store. Inquire for discount on this report @ http://www.rnrmarketresearch.com/contacts/discount?rname=203501 Dallas, TX (PRWEB) October 22, 2014 Market Research Report on Global and Chinese Erythromycin Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Erythromycin industry. The report firstly reviews the basic information...

2014-10-22 23:02:29

The Firm is evaluating Xarelto lawsuits on behalf of individuals who experienced uncontrollable internal bleeding, blood clots, and other serious complications, allegedly due to their use of the blood thinner. New York, New York (PRWEB) October 22, 2014 As Xarelto lawsuits (http://www.thexareltolawsuit.com/ ) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that Janssen Ortho L.L.C. has recalled thousands of bottles of the blood thinner after microbial contamination was...

2014-10-22 08:32:56

Pain Insights, Inc. releases a comprehensive market research study on the impact of hydrocodone rescheduling, Zohydro(TM) ER, and abuse-deterrent formulations on prescribers and the pain market. FAIRFIELD, N.J., Oct. 22, 2014 /PRNewswire/ -- Rescheduling of hydrocodone combination products (HCPs) will impel a major transformation in the pain market, according to a new primary market research study by Pain Insights, Inc., a firm providing market research and consultation exclusively in the...

2014-10-22 08:30:21

DALLAS, October 22, 2014 /PRNewswire/ -- RnRMarketResearch.com adds PharmaPoint: HER2-Positive Breast Cancer - Drug Forecast and Market Analysis to 2023 research reports for United States (US), China and Japan to the cancer drugs market research collection of its online library. The PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023...

2014-10-21 23:15:35

Ongoing and Recent Evidence Shows RA Patients Who Supplement Methotrexate With Folate Therapy Have Better Outcomes, According To Makers of EnLyte With Delta Folate. Sunset, LA (PRWEB) October 21, 2014 Over one million people in the U.S. suffer from rheumatoid arthritis (RA), an autoimmune disease marked by pain, swelling, and stiffness in the joints. The most common first line treatment for RA is methotrexate, a prescription medication belonging to the class of drugs knows as DMARDS....

2014-10-21 12:29:40

However, Restrictions in Drug Coverage and Molecular Testing Limit Patient Access to Biomarker-Associated Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 21, 2014 /PRNewswire/ -- Decision Resources Group finds that the majority of surveyed oncologists in Argentina and Mexico are primarily prescribing biomarker-driven agents for the treatment of HER2-positive breast cancer and EGFR-mutation positive metastatic, non-small-cell lung cancer (NSCLC). However,...


Latest Organic chemistry Reference Libraries

Organometallics
2012-05-17 15:18:17

Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....

Synthetic Metals
2012-05-17 14:54:38

Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...

More Articles (2 articles) »
Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related